Regeneron Pharmaceuticals (REGN34.SA) Q4 2022 Earnings

Nov 3Confirmed
Q1 2022
Q2 2022
Q3 2022
Q4 2022
43.92
67.14
90.35
113.57

Details

Expected EPS
48.898444
Actual EPS
56.979986
Surprise EPS
8.08
Surprise Percent
+16.53%

Description

⁨Regeneron Pharmaceuticals⁩ (⁦REGN34.SA⁩) has reported earnings of ⁦56.979986⁩ per share for ⁦Q4 2022⁩.

0 Comments

Share your thoughts